Esophageal Cancer
- Esophageal cancer comes in two main flavors: squamous cell carcinoma (more often upper/mid esophagus) and adenocarcinoma (usually lower esophagus, the chronic-reflux/Barrett's crowd).
- On a barium swallow the classic look is an irregular, "apple-core" narrowing with shouldered, ragged edges — abrupt, asymmetric, and ugly.
- CT and PET/CT do the staging legwork: looking for wall thickening, fat-plane invasion, regional nodes, and distant spread (liver, lungs, distant nodes).
- Endoscopic ultrasound (EUS) is the king of local T-staging because it actually sees the individual wall layers.
- The esophagus has no serosa, so tumors invade neighbors early — which is exactly why it tends to present late and stage high.
The esophagus is basically a muscular drainpipe with a cruel design flaw: unlike most of the gut, it has no serosa — no tidy outer wrapping to slow an invading tumor down. So when cancer shows up here, it tends to spill into the neighborhood (windpipe, aorta, lymphatics) earlier than you'd like, and patients usually notice only once swallowing gets hard. Our job in imaging is to find it, describe how mean it looks, and map out how far it has wandered.
Two cancers wearing the same costume
Most esophageal cancer is one of two types, and they keep different company.
| Type | Typical location | Classic backstory |
|---|---|---|
| Squamous cell carcinoma | Upper and mid esophagus | Smoking, alcohol; historically the global heavyweight |
| Adenocarcinoma | Lower esophagus / GE junction | Chronic reflux → Barrett's metaplasia |
The punchline: where the tumor sits is a genuine clue to what it is. A lesion hugging the gastroesophageal junction in a longtime heartburn sufferer screams adenocarcinoma; one up in the mid-esophagus in a heavy smoker leans squamous.
What it looks like on a barium swallow
If someone drinks barium and you fluoroscope it going down (the same setup we use for achalasia and other motility problems), cancer announces itself rudely. The textbook sign is the apple-core (or "napkin-ring") lesion: an irregular narrowing with shouldered margins — the edges hang over abruptly instead of tapering politely.
Think of a benign stricture as a gentle highway off-ramp: smooth, symmetric, easing the contrast through. A malignant stricture is a pothole-riddled, half-collapsed tunnel — asymmetric, ragged, with mucosa that's been chewed up. That contrast (pun mildly intended) between smooth and tapered versus abrupt and ulcerated is one of the most useful instincts you can build.
Barium swallow can suggest cancer and show where it is, but it can't tell you how deep it goes or whether nodes are involved. It's the doorbell, not the home tour. The actual diagnosis is made by endoscopy and biopsy.
How CT does the staging legwork
Once cancer is confirmed, contrast-enhanced CT of the chest and abdomen is the workhorse for the big-picture map. You're hunting for:
- Wall thickening — an asymmetric, thickened esophageal wall at the tumor site.
- Loss of fat planes — the dark fat stripes between esophagus and its neighbors (aorta, trachea, pericardium) getting smudged out, which hints at local invasion.
- Regional and distant nodes — enlarged or rounded lymph nodes near the tumor and farther afield.
- Metastatic disease — the usual escape destinations: liver, lungs, and distant nodes.
CT is great at the M (distant spread) and decent at the N (nodes), but it's genuinely poor at fine T-staging — it can't resolve the individual wall layers to tell a T1 from a T2.
EUS: the layer whisperer
That's where endoscopic ultrasound (EUS) earns its keep. By putting the ultrasound probe right up against the wall from inside, EUS resolves the esophageal wall into its distinct layers, so it can judge how deep the tumor burrows (the T) and sample suspicious nearby nodes. It's the local-staging champion in a way cross-sectional imaging simply can't match.
Divide the labor: EUS owns local depth (T) and nearby nodes, CT maps the body, and PET/CT hunts for hidden distant disease. No single test does it all — they're a relay team, not soloists.
PET/CT and finding the sneaky spread
Most of these tumors are FDG-avid, so FDG-PET/CT is excellent at lighting up unsuspected distant metastases and nodes that CT shrugged at. Changing the stage from "operable" to "not operable" changes the patient's whole life, so finding one occult metastatic node really matters.
Not every esophageal mass is cancer, and not every "stricture" is malignant. A long, smooth, symmetric narrowing in a reflux patient is more likely a benign peptic stricture; achalasia gives a smooth, tapered "bird-beak." Abrupt, asymmetric, shouldered, mucosa-destroying narrowing is the malignant pattern. When the morphology is ambiguous, the answer is endoscopy and biopsy, not a confident radiology hunch.
Why it stages high
Come back to that missing serosa. Without an outer wrapper, and with a rich lymphatic network running the length of the esophageal wall, tumors here invade locally and seed nodes early — sometimes nodes well away from the primary. Combine that with symptoms (trouble swallowing) that only show up once the lumen is meaningfully narrowed, and you get a cancer that's frequently advanced by the time anyone images it.
So the one thing to carry out of here: when you see an abrupt, irregular, shouldered narrowing of the esophagus, call it suspicious, get the tissue, and then let CT, EUS, and PET/CT divide up the staging map — because with this tumor, where it has already gone matters as much as what it is.